Nigel P. Shankley
12Patents
4h-index
44Co-inventors
56Inventor score
Filing activity: Jan 12, 1993 → Nov 4, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5912260A | Gastrin and CCK antagonists | Chemistry; Metallurgy | 49 | Expired |
| US5514683A | Bicyclo 2,2,2!octane derivatives | Chemistry; Metallurgy | 15 | Expired |
| US6479531B1 | Gastrin and cholecystokinin receptor ligands | Chemistry; Metallurgy | 7 | Expired |
| US6080871A | Sulfonamides and sulfamides as H.sub.3 receptor antagonists | Chemistry; Metallurgy | 4 | Expired |
| US5486597A | Tetrapeptide derivatives and analogues | Chemistry; Metallurgy | 3 | Expired |
| US6878736B1 | Histamine H3 receptor ligands | Chemistry; Metallurgy | 2 | Expired |
| US5399748A | Derivatives of aspartic acid and glutamic acid having anticholecystokinin activity | Chemistry; Metallurgy | 2 | Expired |
| US7241759B2 | Benzo[1,2,5]thiadiazole compounds | Chemistry; Metallurgy | 2 | Expired |
| US7465808B2 | CCK-1 receptor modulators | Chemistry; Metallurgy | 1 | Expired |
| US7037931B2 | CCK-1 receptor modulators | Chemistry; Metallurgy | 1 | Expired |
| US7550492B2 | Benzo[1,2,5]thiadiazole compounds | Chemistry; Metallurgy | 0 | Active |
| US10040838B2 | CRHR2 peptide agonists and uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.